Structure Database (LMSD)

LMSD: Structure-based search results

LM_ID	Common Name	Systematic Name	Formula	Mass	Main Class	Sub Class
LMFA04010002	17-F4-NeuroP	(4Z,7Z)-9-(3,5-dihydroxy-2-((1E,5Z)-3- hydroxyocta-1,5-dien-1-yl)cyclopentyl) nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010107	ent-17-F4t-NeuroP	(4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010108	ent-10-epi-17-F4c-NeuroP	(4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010109	ent-10-epi-17-F4t-NeuroP	(4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010110	ent-17-F4c-NeuroP	(4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010111	ent-17-epi-17-F4t-NeuroP	(4Z,7Z)-9-((1R,2S,3S,5R)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010112	ent-10,17-diepi-17-F4c-NeuroP	(4Z,7Z)-9-((1R,2R,3S,5R)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010113	ent-10,17-diepi-17-F4t-NeuroP	(4Z,7Z)-9-((1S,2S,3S,5R)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010114	ent-17-epi-17-F4t-NeuroP	(4Z,7Z)-9-((1S,2R,3S,5R)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010115	17-epi-17-F4c-NeuroP	(4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010116	10,17-diepi-17-F4t-NeuroP	(4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010117	10,17-diepi-17-F4c-NeuroP	(4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010118	17-epi-17-F4t-NeuroP	(4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy- 2-((R,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010119	17-F4c-NeuroP	(4Z,7Z)-9-((1R,2S,3R,5S)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010120	10-epi-17-F4t-NeuroP	(4Z,7Z)-9-((1R,2R,3R,5S)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010121	10-epi-17-F4c-NeuroP	(4Z,7Z)-9-((1S,2S,3R,5S)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]
LMFA04010122	17-F4t-NeuroP	(4Z,7Z)-9-((1S,2R,3R,5S)-3,5-dihydroxy- 2-((S,1E,5Z)-3-hydroxyocta-1,5-dien-1- yl)cyclopentyl)nona-4,7-dienoic acid	C₂₂H₃₄O₅	378.2406	Docosanoids [FA04]	Neuroprostanes [FA0401]